FTSE

AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.

The FTSE 100 rose modestly as investors grew more hopeful that diplomatic efforts over Iran could ease tensions. Reports carried by financial outlets in Australia, Singapore and beyond noted stocks inching higher, with markets cautiously pricing in the prospect of talks rather than escalation. Traders are watching for further signs of de-escalation in the region.

London's FTSE 100 rose as falling oil prices eased cost pressures, but defence stocks underperformed the broader market. The session also drew attention to Defence Secretary John Healey, with investors weighing how political and energy-market shifts affect defence and energy shares. Traders read the drop in oil as supportive for companies facing high energy costs, while defence names gave up ground despite ongoing interest in European defence spending.

WOI India has acquired SwiftSeed Ventures and appointed Amar Dixit as chief executive of the business. The deal, reported by The Economic Times, brings the venture firm under WOI India's ownership, with Dixit taking charge of its operations and strategy. Details on the transaction's value and the two firms' plans have not been disclosed.

The UK's FTSE 100 index dropped as rising oil prices and bond yields weighed on European stock markets. The decline, reported by Bloomberg, reflects wider pressure on equities across the continent, with investors responding to higher borrowing costs and energy prices. UK markets are in focus as traders assess how the pullback fits into broader European market weakness.

UK events company Clarion, known for running arms fairs as well as comic and fan conventions, has been sold to a rival in a deal worth £2bn. The transaction involves Informa and private equity group Blackstone, and would affect Clarion's FTSE 100-linked parent structure. The sale pairs two unlikely portfolios under one owner, combining defence trade exhibitions with pop culture shows.

London's FTSE index outperformed other major European stock markets in recent trading, while the euro came under pressure against other currencies. Reports noted strength in UK shares relative to benchmarks in Frankfurt and Paris, with the euro's weakness drawing attention from investors tracking currency movements across the region.

Yahoo Finance UK argues that, based on historical market patterns, one FTSE 250 company would be a smart purchase if the stock market crashes. The piece taps into investor nervousness about a possible downturn and the hunt for shares that historically rebound strongly after sell-offs. It reflects ongoing debate among UK investors about how to position portfolios against market volatility.

Aviva plc, the London-listed insurer, is seeing renewed interest in its share price, quote and trading history as investors look up the stock's latest performance. The FTSE 100 company remains a widely followed insurance and asset management group, and searches for its quote and recent news suggest traders are checking its current valuation and market movements.

Investors are tracking AstraZeneca's London-listed stock (AZN.L), with financial news outlets highlighting its current price, quote data and trading history. The pharmaceuticals giant remains a widely followed name on the FTSE 100, and coverage of its share performance is drawing interest from market watchers monitoring moves in the healthcare sector.

Commentary on UK markets is focusing on how the FTSE 100 responds to three forces: rising bond yields, higher oil prices and shifting global risk sentiment. The analysis argues that higher yields raise borrowing costs and compete with equities, while oil prices feed inflation, and it points to more stable yields and easing geopolitical tensions as conditions that could steady the index.

Market analysts at StoneX are highlighting two setups for traders: the FTSE 100 index and the EUR/USD currency pair. The forecast offers a technical outlook on where these two markets may be headed, giving investors potential entry and exit levels. Traders tracking European equities and the dollar-euro rate are following the analysis for guidance on near-term direction.

London's FTSE 100 index moved higher, with technology shares leading the gains and outweighing investor unease over tensions in the Middle East. Traders appeared to focus on strength in the tech sector despite ongoing geopolitical risk, keeping the benchmark index in positive territory during the session.

Walgreens Boots Alliance, the parent company of UK pharmacy chain Boots, is reportedly close to a deal selling the business to Canada's Weston family for around $9 billion. The sale would put the health and retail group in the hands of one of Canada's best-known retail dynasties, ending years of speculation about the company's future and restructuring under its US owner.

Credo Technology Group Holding, the connectivity chipmaker traded as CRDO, has been added to the FTSE All World Index, prompting debate among investors about whether its share price fairly reflects the company's prospects. Inclusion in the index typically brings buying from passive funds, and analysts are weighing that support against the stock's valuation after recent gains.